Regulatory Open Forum

 View Only
  • 1.  UK importer & hospital/clinic end users

    This message was posted by a user wishing to remain anonymous
    Posted 24-Jan-2024 09:11
    This message was posted by a user wishing to remain anonymous

    Dear all,

    For our UK market we are planning to launch a web shop for one of our products (class IIb implantable, currently MDD approved, but soon MDR approved) as a pilot. The product is intended for professional use. At the moment we are selling our products via an UK distributor (which is also the importer). For this pilot via a web shop, we are going to sell our products directly to hospitals/clinics and end-users. 

    How does this work in terms of 'importers' due to the fact all importers should be listed in the UK database. Are end-users considered as importers and is there a difference for MDD products vs MDR products? 
    And if end-users and considered as importers, how to manage this in case of selling to multiple end-users? Do we have to include all end-users in the UK database? This seems very impractical, is there a 'common sense  way' to handle this?

    Thank you



  • 2.  RE: UK importer & hospital/clinic end users

    Posted 24-Jan-2024 11:14

    Generally speaking, end users are not considered to be importers.  This is the same for the UK and the MDD/MDR alike.  For example, the European Commission's Directorate-General (DG) for Health and Food Safety advised me of that interpretation regarding the MDR.  For the UK, end users don't generally meet the UK regulations' trigger for "supply" or placing on the market.  If instead the end user places the devices on the market or makes them further available on the market, then UK MDR regulatory obligations would ensue.  As long as the end user only uses the devices for their own particular end use, then they aren't supplying or placing the devices on the market.  Note that end users can however trigger certain requirements regarding custom-made devices.



    ------------------------------
    Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
    Principal Consultant
    Ridgway, CO
    United States
    © Copyright by ComplianceAcuity, Inc. All rights reserved.
    ------------------------------



  • 3.  RE: UK importer & hospital/clinic end users

    Posted 25-Jan-2024 02:18

    Dear Anonymous,

    Thank you for forwarding your questions. Kevin provided the correct answer-no MDR article 13 Importer requirements for the end user. However, it's worth noting that there may be local regulations for products sold directly to consumers in certain countries. Some products may require pharmacy involvement. It is recommended to check for any restrictions on direct sales to patients for a Class IIb implantable product, considering local distribution requirements. For example, in Germany, initially, COVID tests could only be performed by professionals due to specific objectives, but this changed during the pandemic. This illustrates local variations in distribution requirements, distinct from CE Marking requirements, and these can differ from country to country. Additionally, reimbursement policies may impact product distribution.

    As I write this, it occurred to me that you might be referring to an Annex XVI product. I find it interesting, and I cannot imagine there would be any restrictions, but please share if there are any specific considerations in this context.

    Dera Kevin,

    You have nicely outlined that the Importer requirements, according to Article 13, do not apply to the end user, whether it is a healthcare provider, laboratory (for IVDs), or the patient himself.

    Thank you for sharing your information retrieved directly from the Commission directly. Would you be able to share the actual feedback? Certainly, respecting GDPR, the name may be deleted.

    I do not understand the last comment. Custom-made device. If I am a patient and I change my medical device to my needs, what should I do?  Look at the MDR?



    ------------------------------
    Ludger Moeller
    President, MDSS GmbH
    l.moeller@mdssar.com
    ------------------------------



  • 4.  RE: UK importer & hospital/clinic end users

    Posted 25-Jan-2024 09:59

    Thank you for your questions Ludger.

    In part, the Commission told me that in in both Regulations [(EU) 2017/745 (Article 2(33)) and (EU) 2017/746 (Article 2(26)], "importer" is defined as "any natural or legal person established within the Union that places a device from a third country on the Union market". Therefore, if a manufacturer established outside the EU places a device on the EU market directly to a user, in such a case there is no importer, as there is no person established within the Union placing a device from a third country.

    The UK MDR contains certain obligations for the healthcare professional end-user if the device is a custom-made device.  I only mentioned that to assure it was clear that, even if the direct-sale end-user is not an importer, such end-user can still have certain regulatory obligations (though not importer obligations) when the subject device is a custom-made device.  In other words, I mentioned that so it is clear that, just because an end-user is exempt from importer obligations, it remains that they can still be subject to certain other obligations.  Didn't mean to confuse the importer issue.



    ------------------------------
    Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
    Principal Consultant
    Ridgway, CO
    United States
    © Copyright by ComplianceAcuity, Inc. All rights reserved.
    ------------------------------



  • 5.  RE: UK importer & hospital/clinic end users

    Posted 25-Jan-2024 02:50

    Kevin Randall has already mentioned that direct import to end users does not make them into importers and from a regulatory perspective, no importation takes place. Obviously, importation from the perspective of logistics and customs still happens and those requirements must be fully met. 

    There is a point that Kevin only touches on and this is about the responsibilities of that end user ordering a device from outside their market: they are taking up responsibities regarding the safety and performance of the device. Sooner or later there will be a case where a hospital finds themselves accused of injuring a patient with a device that should not have been used on the UK market (e.g. counterfeight). What you could do, is to add the role of the regulatory importer. That is a company that is on the label as the importer, although they are not directly involved in the logistics. They add that extra layer of protection against non-compliant devices that is intended by this particular role. 

    There are companies offering this service. Reach out if you want to know more about that. 



    ------------------------------
    Ronald Boumans
    MDR Expert
    Super PRRC
    Netherlands
    ------------------------------



  • 6.  RE: UK importer & hospital/clinic end users

    Posted 25-Jan-2024 10:26
    Edited by Kevin Randall 25-Jan-2024 10:27

    While I can see potential benefits of voluntarily creating an importer (and additional regulatory burden) to add a layer of checks and balances, I strongly advise against the basis being that end users need regulation as having taken up responsibilities regarding safety and performance. That in my opinion opens the door to more frivolous litigation against healthcare providers and/or manufacturers, and to more burdensome overregulation. It also seems to run contrary to a most fundamental tenet of Europe's longstanding "common framework" and regulatory approach, which is to distinguish regulated economic operators and protect the public stakeholders on whom, or by whom, the devices are used.

    If such a "virtual" (my terminology) importer is voluntarily invented/created by the stakeholders, then the manufacturer needs to remember that it will be required to execute a placing on the market of those devices to said virtual importer.  Specifically, the manufacturer and importer would be required to execute (and thereafter be able to prove) that there was an offer or an agreement (written or verbal) by the manufacturer to transfer ownership, possession or other property right concerning the product in question to the importer rather than the end user.  Again, such an arrangement could certainly be of value to reduce liability risk in those cases where the manufacturer has the bandwidth for such voluntary additional regulatory burden.  In fact, I have advised clients to do this at times, though not based on asserting that the end users had taken up responsibilities regarding safety and performance.



    ------------------------------
    Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
    Principal Consultant
    Ridgway, CO
    United States
    © Copyright by ComplianceAcuity, Inc. All rights reserved.
    ------------------------------



  • 7.  RE: UK importer & hospital/clinic end users

    Posted 25-Jan-2024 06:30

    An interesting one for sure.

    I would assume that this would be covered un Art 6 of the MDR for distance sales. MDCG 2021-27 rev 1 Q2 has the example of a consumer (let's assume end-user, including a healthcare institution purchasing for use within their own legal entity) purchasing a device from a third-country and not being considered as the importer as this situation is not seen to be placing the device on the market. But I don't think MDCG 2021-27 helps clarify the distance sales aspect, because footnote 11 mentions it and says it applies, but does not clarify how it applies if a manufacturer in a third-country were to offer their product for sale in the EU via the internet. The HPRA did provide some helpful examples of transactions in one of their newsletters, but it does not include a direct to consumer purchase example.

    The UK Regs don't cover distance sales currently. It was covered in the MHRA's consultation back in 2021 and the feedback and the MHRA's response would suggest (although that was in June 2022) that requirements for distance sales will be included in the future UK regulations. And for the UK, it is important to remember that the EU MDR and IVDR are applied in Northern Ireland, so those requirements do apply there (as well as UK registration requirements). 



    ------------------------------
    Ed Ball
    Manager, Intelligence & Innovation
    United Kingdom
    ------------------------------



  • 8.  RE: UK importer & hospital/clinic end users

    Posted 25-Jan-2024 07:18

    Hi Anon,

    as an additional thought: Talk to your UK responsible person to see how they would interpret this. Maybe it would even be possible to have them as a pro-forma importer for these devices, so that you have clear responsibilities.

    Sometimes the consequences are difficult to assess and you would like to avoid that your customers suddenly have responsibilities they did not realize, even if they might not considered to be importers (e.g. in Switzerland direct import and use of medical devices under certain circumstances might lead to a health institution being fully responsible for the conformity of the device without them being an importer, see here).

    Best regards, Christoph



    ------------------------------
    Christoph Kiesselbach
    Schrack & Partner
    Reutlingen
    Germany
    ------------------------------



  • 9.  RE: UK importer & hospital/clinic end users

    This message was posted by a user wishing to remain anonymous
    Posted 31-Jan-2024 09:07
    This message was posted by a user wishing to remain anonymous

    Thank you all for your comments. 

    We have contacted our Authorised Representative in the UK and they answered the following:
    The MHRA has confirmed that in the case of distance sales, the end user is not considered the importer unless they are placing the device on the market or making it available. Therefore, if there is no importer there is currently no requirement for registration within the UK database. 




  • 10.  RE: UK importer & hospital/clinic end users

    Posted 31-Jan-2024 10:09

    Hi Anon,

    thank you for the update. I think it is helpful to have that confirmation.

    Best regards, Christoph



    ------------------------------
    Christoph Kiesselbach
    Schrack & Partner
    Reutlingen
    Germany
    ------------------------------